FDA phê duyệt mở rộng phạm vi sử dụng các loại thuốc điều trị ung thư tuyến tụy đang trong giai đoạn nghiên cứu.
Đuôi trang web .gov cho biết đây là trang web chính thức.
Noi dung day du cua bai viet
FDA is announcing that it issued a “safe to proceed” letter to Revolution Medicines, allowing the sponsor to initiate an expanded access treatment protocol (EAP) for its experimental pancreatic cancer drug, daraxonrasib.
Câu hỏi thường gặp
Which products are related to this article?
No strongly related product has been identified yet. The match updates automatically when the article or catalog changes.
How can I view the medicines discussed in this article?
Use the related product cards below the article to review available specifications, prices, product information, and reviews.
Does this article replace advice from a doctor or pharmacist?
No. This content is for general information and health education only. Follow the prescription and individual guidance provided by qualified healthcare professionals.
